• Report Adverse Event or Product Quality Complaint
  • Global Site
AstraZeneca Medical Information
  • Prescribing Information
  • Resources
    • Congress Library
    • Our Pipeline
    • AZ Clinical Trials
    • Externally Sponsored Scientific Research
  • Connect
    • Send MIR
    • Give Feedback

Search Medical Information

Prescribing Information

  • ACALABRUTINIB (CALQUENCE) 100 mg Capsule
  • ANASTROZOLE (ARIMIDEX) 1 mg Tablet
  • ANIFROLUMAB (SAPHNELO) 300 mg/2 mL (150 mg/mL) Concentrate for Solution for Infusion (IV)
  • BICALUTAMIDE (CASODEX) 50 mg Tablet
  • BUDESONIDE (BUDECORT RESPULES) 250 mcg/mL (500 mcg/2 mL) Nebulizing Suspension (Sterile)
  • BUDESONIDE (BUDECORT RESPULES) 500 mcg/mL (1000 mcg/2 mL) Nebulizing Suspension (Sterile)
  • BUDESONIDE (BUDECORT TURBUHALER) 200 mcg/dose Powder for Inhalation
  • BUDESONIDE + FORMOTEROL FUMARATE (SYMBICORT TURBUHALER) 160 mcg/4.5 mcg per dose Powder for Inhalation
  • BUDESONIDE + FORMOTEROL FUMARATE DIHYDRATE (SYMBICORT TURBUHALER) 80 mcg/4.5 mcg per dose Powder for Inhalation
  • BUDESONIDE / FORMOTEROL FUMARATE DIHYDRATE (SYMBICORT RAPIHALER) 160 mcg/4.5 mcg per Actuation Inhalation Aerosol (Pressurized Suspension for Inhalation)
  • BUDESONIDE / FORMOTEROL FUMARATE DIHYDRATE (SYMBICORT RAPIHALER) 80 mcg/4.5 mcg per Actuation Inhalation Aerosol (Pressurized Suspension for Inhalation)
  • BUDESONIDE / FORMOTEROL FUMARATE DIHYDRATE (SYMBICORT TURBUHALER) 320 mcg/9 mcg per dose Powder for Inhalation
  • BUDESONIDE/ GLYCOPYRRONIUM/ FORMOTEROL FUMARATE (BREZTRI AEROSPHERE) 160 mcg/7.2 mcg /4.8 mcg per actuation, pressurized suspension for inhalation
  • CAPIVASERTIB (TRUQAP) 160 mg Film-Coated Tablet
  • CAPIVASERTIB (TRUQAP) 200 mg Film-Coated Tablet
  • DAPAGLIFLOZIN (FORXIGA) 10 mg Tablet
  • DAPAGLIFLOZIN + METFORMIN HYDROCHLORIDE (XIGDUO XR) 10 mg/1000 mg Film-Coated Tablet
  • DAPAGLIFLOZIN + METFORMIN HYDROCHLORIDE (XIGDUO XR) 10 mg/500 mg Film-Coated Tablet
  • DAPAGLIFLOZIN + METFORMIN HYDROCHLORIDE (XIGDUO XR) 5 mg/1000 mg Film-Coated Tablet
  • DAPAGLIFLOZIN/SITAGLIPTIN (SIDAPVIA) 10 mg/100 mg Film-Coated Tablet
  • DURVALUMAB (IMFINZI) 120 mg/2.4 mL (50 mg/mL) Concentrate for Solution for IV Infusion
  • DURVALUMAB (IMFINZI) 500 mg/10 mL (50 mg/mL) Concentrate for Solution for IV Infusion
  • ESOMEPRAZOLE (NEXIUM) 10 mg Gastro Resistant Granules for Oral Suspension
  • ESOMEPRAZOLE (NEXIUM) 20 mg Enteric Coated Tablet
  • ESOMEPRAZOLE (NEXIUM) 40 mg Enteric Coated Tablet
  • ESOMEPRAZOLE (NEXIUM) 40 mg Powder for Solution for Injection (IV)
  • FELODIPINE + METOPROLOL SUCCINATE (LOGIMAX) 5mg/47.5mg (equiv to 50mg Metoprolol tartrate) Extended Release Tablet
  • FULVESTRANT (FASLODEX) 250 mg/5 mL Solution for Injection (IM)
  • GEFITINIB (IRESSA) 250 mg Film-Coated Tablet
  • GOSERELIN (ZOLADEX) 3.6 mg Depot in Pre-filled Syringe (SC Injection)
  • GOSERELIN ACETATE (ZOLADEX LA) 10.8 mg Depot Solution for Subcutaneous Injection
  • METOPROLOL SUCCINATE (BETAZOK) 23.75mg (equiv to Meto Tartrate 25 mg) Controlled Release Tablet
  • METOPROLOL SUCCINATE (BETAZOK) 95mg (equiv to 100 mg Metoprolol Tartrate) Controlled Release Tablet
  • METOPROLOL TARTRATE (BETALOC) 50 mg Tablet
  • OLAPARIB (LYNPARZA) 100 mg Film-Coated Tablet
  • OLAPARIB (LYNPARZA) 150 mg Film-Coated Tablet
  • OSIMERTINIB (TAGRISSO) 80 mg Film-Coated Tablet
  • OSIMERTINIB (TAGRISSO) 40 mg Film-Coated Tablet
  • PALIVIZUMAB (SYNAGIS) 50 mg/0.5 mL Solution for Injection
  • PALIVIZUMAB (SYNAGIS) 100 mg/mL Solution for Injection
  • ROSUVASTATIN (CRESTOR) 10 mg Tablet
  • ROSUVASTATIN (CRESTOR) 20 mg Tablet
  • ROSUVASTATIN (CRESTOR) 40 mg Tablet
  • ROSUVASTATIN (CRESTOR) 5 mg Tablet
  • SAXAGLIPTIN + DAPAGLIFLOZIN (QTERN) 5 mg/10 mg Film-Coated Tablet
  • SELUMETINIB SULFATE (KOSELUGO) 10 mg capsule
  • SELUMETINIB SULFATE (KOSELUGO) 25 mg capsule
  • SODIUM ZIRCONIUM CYCLOSILICATE (LOKELMA) 5 g powder for oral suspension
  • SODIUM ZIRCONIUM CYCLOSILICATE (LOKELMA) 10 g powder for oral suspension
  • TAMOXIFEN (NOLVADEX-D) 20 mg Tablet
  • TERBUTALINE SULFATE (BRICANYL) 2.5 mg Tablet
  • TICAGRELOR (BRILINTA) 90mg Film-Coated Tablet
  • TRASTUZUMAB DERUXTECAN (ENHERTU) 100 mg powder for concentrate for solution for infusion
  • TREMELIMUMAB (IMJUDO) 25 mg/1.25 mL (20 mg/mL) Concentrate for Solution for Infusion (IV)
  • TREMELIMUMAB (IMJUDO) 300 mg/15 mL (20 mg/mL) Concentrate for Solution for Infusion (IV)

Request a field medical follow-up

AstraZeneca Logo

This platform is provided as service to healthcare professionals by AstraZeneca Philippines, for medical educational purposes only.

©2024 AstraZeneca. All rights reserved.

PH-10554.

Last Updated 5/24

Contact Us

About Us

AstraZeneca.com

Survey Feedback

Privacy Notice

Legal Notice

Cookie Notice

Global Site

Report Adverse Event or Product Quality Complaint

Privacy NoticeLegal NoticeCookie Notice

Welcome to AstraZeneca Philippines Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the Philippines, for medical educational purposes only. AstraZeneca does not engage in the promotion of unregistered products or unapproved indications. The dissemination of this information may be subject to different medical and regulatory requirements in other countries

Are you a healthcare professional practicing in the Philippines?

No